Catalyst Pharmaceuticals, Inc.'s and KYE Pharmaceuticals'
Catalyst Pharmaceuticals, Inc.’s and KYE Pharmaceuticals’ Lawsuit in Canadian Federal Court Quashes the Notice of Compliance (NOC) for Ruzurgi® June 03, 2021 13:20 ET | Source: Catalyst Pharmaceuticals, Inc. Catalyst Pharmaceuticals, Inc. - Without an NOC, Ruzurgi is without a Marketing Authorization in Canada - Matter Remanded Back to Health Canada to Provide a More Transparent Record of Its Decision in Light of Firdapse ® ’s Data Protection CORAL GABLES, Fla....
United States Douglas Reynolds Patrickj Mcenany Health Canada On Catalyst Pharmaceuticals Canadian Federal Court
Source: globenewswire.com